SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (957)3/24/2004 11:04:11 AM
From: Jibacoa  Read Replies (1) | Respond to of 1005
 
INGN seems to be responding to the announcement that they will update their progress in the development of Advexin and INGN 241 at the 95th annual meeting of the AACR in Orlando, FL.

Nine abstracts will be presented during the conference:

Two INGN 241 abstracts will be presented on March 28, two on March 30 and four on March 31 and one Advexin abstract will be presented on March 30.


biz.yahoo.com

Bernard